Artemisinin suppresses aerobic glycolysis in thyroid cancer cells by downregulating hif-1a, which is increased by the xist/mir-93/hif-1a pathway

HIGHLIGHTS

• who: Fei Yang and collaborators from the Department of Otolaryngology Head and Neck, Fourth Hospital of Hebei Medical University, China, Cancer Institute, Fourth Hospital of Hebei Medical University, China have published the paper: Artemisinin suppresses aerobic glycolysis in thyroid cancer cells by downregulating HIF-1a, which is increased by the XIST/miR-93/HIF-1a pathway, in the Journal: PLOS ONE of March/27,/2023
• what: The authors will verify the mechanism that XIST regulates glycolysis of thyroid cancer cells through HIF-1a, and explore XIST as a biomarker of thyroid cancer progression and corresponding . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.